(Q35017769)

5 August 2017

1 reference

title

Current and future hepatitis C virus diagnostic testing: problems and advancements (English)

1 reference

5 August 2017

1 reference

1 reference

Ayaz M Majid

1

1 reference

PubMed ID

12467764

5 August 2017

David R Gretch

series ordinal

2

1 reference

PubMed ID

12467764

5 August 2017

language of work or name

1 reference

1 October 2002

1 reference

5 August 2017

Microbes and Infection

1 reference

5 August 2017

4

1 reference

5 August 2017

12

1 reference

5 August 2017

1227-1236

1 reference

Hepatitis C: the clinical spectrum of disease

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Low risk of sexual transmission of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

The hepatitis C virus genome: a guide to its conserved sequences and candidate epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Clinical use of hepatitis C virus tests for diagnosis and monitoring during therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Use and interpretation of HCV diagnostic tests in the clinical setting

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Role of humoral immune responses in hepatitis B and C virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Immunogenicity and antigenicity of the ATPase/helicase domain of the hepatitis C virus non-structural 3 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Recovery efficiences on nucleic acid extraction kits as measured by quantitative LightCycler PCR

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Cooperative oligonucleotides mediating direct capture of hepatitis C virus RNA from serum.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Calibration of HCV working reagents for NAT assays against the HCV international standard. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Standardization of hepatitis C virus RNA quantification

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Clinical usefulness of the branched DNA assay version 2 in predicting the efficacy of Interferon treatment in a group of chronic HCV patients based on serotype

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Measuring hepatitis C viremia in clinical samples: can we trust the assays?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Real-time detection system for quantification of hepatitis C virus genome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Quantitation of HCV RNA using real-time PCR and fluorimetry

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Characterization of the quantitative HCV NASBA assay

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Clinical significance of hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene).

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Therapy of hepatitis C: overview

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Sustained viral response is rarely achieved in patients with high viral load of HCV RNA by excessive interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

HCV genotypes--role in pathogenesis of disease and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

10-Year follow-up after interferon-alpha therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Early predictors of response to treatment in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Clinical implications of hepatitis C viral kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901650-7

7 January 2021

10.1016/S1286-4579(02)01650-7

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12467764